May 13, 2025   SOURCE: PR NewsWire

Akadeum Unveils Expanded Capability of Microbubbles for Integration on existing C> platforms at ASGCT 2025

ANN ARBOR, Mich., May 13, 2025 /PRNewswire/ -- Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announces the broad integration capability of its flagship product, microbubble-based cell separation.

Microbubble integration into existing platforms enables scaled-up centralized and decentralized cell therapies, reducing footprint and cost. By leveraging microbubble technology, users gain a reduced footprint for cell therapy manufacturing, seamless integration, and healthier cells.

Akadeum is unveiling this advancement and attending alongside partners at the American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting in New Orleans, May 13th-16(th). Throughout the conference, multiple presentations demonstrate the ability of microbubbles to accelerate the next generation of cell therapies. The goal of Akadeum's integration program has been to integrate microbubbles with practically any platform for any starting material and to support process development with a shelved GMP-grade product.

Akadeum's ASGCT agenda includes:

    --  A presentation by Dr. Alex Sargent, Director of Process Development,
        Cell and Gene Therapy, of Charles River Laboratories on Thursday, May
        15(th), at 5 pm CT: "Next Generation Cell Isolation: Replace Magnetics
        with Microbubbles for More Doses in a Smaller Footprint with Seamless
        Integration". Dr. Sargent will discuss data that shows how to achieve
        highly pure T cells and improved recovery in significantly less time
        while maintaining cellular phenotypes, highlighting critical
        improvements towards a shortened CAR T manufacturing process.
    --  Results from Lonza's integration of Akadeum's Human T Cell Leukopak
        Isolation Kit on their Cocoon(®) Platform will be available for viewing
        at Lonza's poster 1796 at 5:30 pm CT on Thursday, May 15(th). By
        integrating microbubbles onto the Cocoon Platform, Lonza successfully
        increased throughput via the streamlined isolation process and achieved
        consistent, reproducible high purity and viability along with desired
        phenotypes for CAR T therapy applications.
    --  Akadeum will present workflow integration data during the networking
        session at Poster 1797 on Thursday, May 15th, from 5:30 to 7 pm CT.
    --  At Booth #1748, attendees can obtain protocols for cell separation
        directly in apheresis material bags (other bags also compatible), how to
        use microbubbles with existing cell washing instrumentation, and enroll
        in the Evaluation Program, an opportunity for scientists to see the
        microbubbles in their lab with an Akadeum scientist.

To schedule a meeting at ASGCT, please visit https://www.akadeum.com/contact/

About Akadeum Life Sciences

Akadeum Life Sciences is pioneering buoyancy-based separation technologies that enable more effective and scalable cell isolation. Our mission is to create separation technologies to advance human health. We envision a world where innovative separations empower researchers and clinicians to unlock breakthroughs in diagnostics, therapeutics, and basic research.

For more information, visit akadeum.com or follow our journey to improve cell therapy on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/akadeum-unveils-expanded-capability-of-microbubbles-for-integration-on-existing-cgt-platforms-at-asgct-2025-302451545.html

SOURCE Akadeum Life Sciences Inc